iMED Pharma Inc. is a privately held Canadian ophthalmic company headquartered in Montreal, Quebec, Canada. It has been operating since 1989 and focuses on solutions for ocular surface disease and dry eye management that serve ophthalmologists, optometrists, and other eye care professionals globally. It develops and provides a broad portfolio of products designed to help diagnose and manage dry eye and related surface disorders.